SAN JOSE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the third quarter ended September 30, 2008, after the close of market on October 29.
VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT / 5:00 p.m. ET on October 29. This call will be webcast live for all investors and archived on the company's website at http://www.vnus.com.
How to Access the Teleconference Webcast
Go to the home page of the VNUS investor relations website at http://ir.vnus.com/ and click on the webcast icon. From this site, you can listen to the teleconference, assuming that your computer system is configured properly.
How to Access the Live Teleconference
Dial-in #: (303) 262-2006. To participate, please dial in approximately 5-10 minutes before the teleconference is scheduled to begin. The operator will take your name and connect your line with the meeting. A phone replay will be available for seven days after the live call at (303) 590-3000, code 11120881#.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com .
CONTACT: Peter Osborne, Chief Financial Officer and Vice President of
Finance and Administration of VNUS Medical Technologies, Inc.,
+1-408-360-7499, ir@vnus.com
Web site: http://www.vnus.com/
